{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T05:10:23Z","timestamp":1792559423126,"version":"4.5.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2024,8,2]],"date-time":"2024-08-02T00:00:00Z","timestamp":1722556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,8,2]],"date-time":"2024-08-02T00:00:00Z","timestamp":1722556800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Intern Emerg Med"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1007\/s11739-024-03725-1","type":"journal-article","created":{"date-parts":[[2024,8,2]],"date-time":"2024-08-02T16:32:24Z","timestamp":1722616344000},"page":"2193-2199","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Aromatase inhibitor-induced bone loss osteosarcopenia in older patients with breast cancer: effects of the RANK\/RANKL system\u2019s inhibitor denosumab vs. bisphosphonates"],"prefix":"10.1007","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1406-0114","authenticated-orcid":false,"given":"Andrea","family":"Casabella","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3526-5503","authenticated-orcid":false,"given":"Francesca","family":"Paladin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9956-0216","authenticated-orcid":false,"given":"Claudia","family":"Bighin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8278-793X","authenticated-orcid":false,"given":"Silvia","family":"Ottaviani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1510-1819","authenticated-orcid":false,"given":"Cristina","family":"Marelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4091-4686","authenticated-orcid":false,"given":"Marta","family":"Ponzano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6289-9144","authenticated-orcid":false,"given":"Alessio","family":"Signori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6403-6905","authenticated-orcid":false,"given":"Giuseppe","family":"Murdaca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5396-0932","authenticated-orcid":false,"given":"Maurizio","family":"Cutolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8789-4964","authenticated-orcid":false,"given":"Luigi","family":"Molfetta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5068-8884","authenticated-orcid":false,"given":"Alessio","family":"Nencioni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9269-5089","authenticated-orcid":false,"given":"Sabrina","family":"Paolino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9546-5841","authenticated-orcid":false,"given":"Lucia","family":"Del Mastro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4303-7252","authenticated-orcid":false,"given":"Fiammetta","family":"Monacelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,2]]},"reference":[{"issue":"4","key":"3725_CR1","doi-asserted-by":"publisher","first-page":"e214708","DOI":"10.1001\/jamanetworkopen.2021.4708","volume":"4","author":"L Rahib","year":"2021","unstructured":"Rahib L, Wehner MR, Matrisian LM, Nead KT (2021) Estimated projection of US cancer incidence and death to 2040. JAMA Netw Open. 4(4):e214708. https:\/\/doi.org\/10.1001\/jamanetworkopen.2021.4708","journal-title":"JAMA Netw Open."},{"issue":"3","key":"3725_CR2","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1007\/s10549-017-4448-5","volume":"166","author":"M Lodi","year":"2017","unstructured":"Lodi M et al (2017) Breast cancer in elderly women and altered clinico-pathological characteristics: a systematic review. Breast Cancer Res Treat 166(3):657\u2013668. https:\/\/doi.org\/10.1007\/s10549-017-4448-5","journal-title":"Breast Cancer Res Treat"},{"issue":"11","key":"3725_CR3","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1016\/s1357-2725(02)00052-3","volume":"34","author":"S Eppenberger-Castori","year":"2002","unstructured":"Eppenberger-Castori S et al (2002) Age-associated biomarker profiles of human breast cancer. Int J Biochem Cell Biol 34(11):1318\u20131330. https:\/\/doi.org\/10.1016\/s1357-2725(02)00052-3","journal-title":"Int J Biochem Cell Biol"},{"issue":"3","key":"3725_CR4","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.critrevonc.2011.12.004","volume":"83","author":"P Carli","year":"2012","unstructured":"Carli P et al (2012) Target therapy in elderly breast cancer patients. Crit Rev Oncol Hematol 83(3):422\u2013431. https:\/\/doi.org\/10.1016\/j.critrevonc.2011.12.004","journal-title":"Crit Rev Oncol Hematol"},{"issue":"4","key":"3725_CR5","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1080\/02841860802001467","volume":"47","author":"NH Bjarnason","year":"2008","unstructured":"Bjarnason NH, Hitz M, Jorgensen NR, Vestergaard P (2008) Adverse bone effects during pharmacological breast cancer therapy. Acta Oncol 47(4):747\u2013754. https:\/\/doi.org\/10.1080\/02841860802001467","journal-title":"Acta Oncol"},{"issue":"9992","key":"3725_CR6","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/S0140-6736(15)60995-3","volume":"386","author":"M Gnant","year":"2015","unstructured":"Gnant M et al (2015) Adjuvant denosumab in breast cancer (ABCSG-18): a multicentre, randomised, double-blind, placebo-controlled trial. Lancet 386(9992):433\u2013443. https:\/\/doi.org\/10.1016\/S0140-6736(15)60995-3","journal-title":"Lancet"},{"key":"3725_CR7","doi-asserted-by":"publisher","unstructured":"M S LeBoff et al.,\u201dThe clinician's guide to prevention and treatment of osteoporosis\u201d, Osteoporos Int. 2022 Oct;33(10):2049\u20132102. https:\/\/doi.org\/10.1007\/s00198-021-05900-y. Epub 2022 Apr 28, https:\/\/doi.org\/10.1007\/s00198-021-05900-y","DOI":"10.1007\/s00198-021-05900-y 10.1007\/s00198-021-05900-y"},{"key":"3725_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jbo.2017.03.001","volume":"7","author":"P Hadji","year":"2017","unstructured":"Hadji P et al (2017) Management of Aromatase Inhibitor-Associated Bone Loss (AIBL) in postmenopausal women with hormone sensitive breast cancer: Joint position statement of the IOF, CABS, ECTS, IEG, ESCEO IMS, and SIOG. J Bone Oncol 7:1\u201312. https:\/\/doi.org\/10.1016\/j.jbo.2017.03.001","journal-title":"J Bone Oncol"},{"issue":"3","key":"3725_CR9","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.tjog.2018.04.011","volume":"57","author":"J Taiwan","year":"2018","unstructured":"Taiwan J (2018) A study of the value of trabecular bone score in fracture risk assessment of postmenopausal women. Obstet Gynecol. 57(3):389\u2013393. https:\/\/doi.org\/10.1016\/j.tjog.2018.04.011","journal-title":"Obstet Gynecol."},{"key":"3725_CR10","doi-asserted-by":"publisher","first-page":"818","DOI":"10.7326\/m15-1361","volume":"166","author":"A Qaseem","year":"2017","unstructured":"Qaseem A, Forciea MA, McLean RM, Denberg TD, Barry MJ, Cooke M, Fitterman N, Harris RP, Humphrey LL, Kansagara D, McLean RM, Mir TP, Sch\u00fcnemann HJ (2017) Treatment of low bone density or osteoporosis to prevent fractures in men and women: a clinical practice guideline update from the American College of Physicians (in Eng). Ann Intern Med 166:818\u2013839. https:\/\/doi.org\/10.7326\/m15-1361","journal-title":"Ann Intern Med"},{"key":"3725_CR11","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1002\/jbmr.1479","volume":"27","author":"S Papapoulos","year":"2012","unstructured":"Papapoulos S, Chapurlat R, Libanati C, Brandi ML, Brown JP et al (2012) Five years of denosumab exposure in women with postmenopausal osteoporosis: results from the first two years of the FREEDOM extension (in Eng). J Bone Miner Res 27:694\u2013701. https:\/\/doi.org\/10.1002\/jbmr.1479","journal-title":"J Bone Miner Res"},{"key":"3725_CR12","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/S0140-6736(15)60995-3","volume":"386","author":"M Gnant","year":"2015","unstructured":"Gnant M et al (2015) Adjuvant denosumab in breast cancer (ABCSG-18): a multicentre, randomised, double-blind, placebo-controlled trial (in Eng). Lancet 386:433\u2013443","journal-title":"Lancet"},{"key":"3725_CR13","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/j.bone.2010.11.020","volume":"201148","author":"R Baron","year":"2011","unstructured":"Baron R et al (2011) Denosumab and bisphosphonates: different mechanisms of action and effects. Bone. 201148:677\u2013692","journal-title":"Bone."},{"issue":"10","key":"3725_CR14","doi-asserted-by":"publisher","first-page":"903657","DOI":"10.3389\/fcell.2022.903657","volume":"26","author":"L Marcadet","year":"2022","unstructured":"Marcadet L et al (2022) The roles of RANK\/RANKL\/OPG in cardiac, skeletal, and smooth muscles in health and disease. Front Cell Dev Biol. 26(10):903657. https:\/\/doi.org\/10.3389\/fcell.2022.903657","journal-title":"Front Cell Dev Biol."},{"key":"3725_CR15","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1093\/annonc\/mdv617","volume":"27","author":"P Hadji","year":"2016","unstructured":"Hadji P, Coleman RE, Wilson C et al (2016) Adjuvant bisphosphonates in early breast cancer: consensus guidance for clinical practice from a European panel. Ann Oncol 27:379\u2013390","journal-title":"Ann Oncol"},{"key":"3725_CR16","doi-asserted-by":"publisher","first-page":"46","DOI":"10.5152\/eurjrheum.2016.048","volume":"4","author":"T S\u00f6zen","year":"2017","unstructured":"S\u00f6zen T, \u00d6z\u0131\u015f\u0131k L, Ba\u015faran N (2017) An overview and management of osteoporosis. Eur J Rheumatol 4:46\u201356","journal-title":"Eur J Rheumatol"},{"issue":"1","key":"3725_CR17","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.jceh.2021.03.015","volume":"12","author":"A Anand","year":"2022","unstructured":"Anand A et al (2022) European Working Group on Sarcopenia in Older People (EWGSOP2) criteria with population-based skeletal muscle index best predicts mortality in asians with cirrhosis. J Clin Exp Hepatol 12(1):52\u201360. https:\/\/doi.org\/10.1016\/j.jceh.2021.03.015","journal-title":"J Clin Exp Hepatol"},{"issue":"13","key":"3725_CR18","doi-asserted-by":"publisher","first-page":"1218206","DOI":"10.3389\/fonc.2023.1218206","volume":"7","author":"Xu Jing","year":"2023","unstructured":"Jing Xu et al (2023) The recent progress of endocrine therapy-induced osteoporosis in estrogen-positive breast cancer therapy. Front Oncol. 7(13):1218206. https:\/\/doi.org\/10.3389\/fonc.2023.1218206","journal-title":"Front Oncol."},{"key":"3725_CR19","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1056\/NEJMoa0809493","volume":"361","author":"SR Cummings","year":"2009","unstructured":"Cummings SR et al (2009) Denosumab for prevention of fractures in postmenopausal women with osteoporosis. N Engl J Med. 361:756\u2013765. https:\/\/doi.org\/10.1056\/NEJMoa0809493","journal-title":"N Engl J Med."},{"key":"3725_CR20","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-017-4140-y","author":"MR McClung","year":"2017","unstructured":"McClung MR et al (2017) Effect of denosumab on trabecular bone score in postmenopausal women with osteoporosis. Osteoporos Int. https:\/\/doi.org\/10.1007\/s00198-017-4140-y","journal-title":"Osteoporos Int"},{"key":"3725_CR21","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.bone.2014.12.062","volume":"75","author":"S Di Gregorio","year":"2015","unstructured":"Di Gregorio S et al (2015) Comparison between different bone treatments on areal bone mineral density (aBMD) and bone microarchitectural texture as assessed by the trabecular bone score (TBS). Bone. 75:138\u201343. https:\/\/doi.org\/10.1016\/j.bone.2014.12.062","journal-title":"Bone."},{"issue":"3","key":"3725_CR22","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1002\/jcsm.12567","volume":"11","author":"B Kirk","year":"2020","unstructured":"Kirk B et al (2020) Osteosarcopenia: epidemiology, diagnosis, and treatment-facts and numbers. J Cachexia Sarcopenia Muscle. 11(3):609\u2013618. https:\/\/doi.org\/10.1002\/jcsm.12567","journal-title":"J Cachexia Sarcopenia Muscle."},{"issue":"8","key":"3725_CR23","doi-asserted-by":"publisher","first-page":"3214","DOI":"10.1172\/JCI125915","volume":"129","author":"N Bonnet","year":"2019","unstructured":"Bonnet N et al (2019) RANKL inhibition improves muscle strength and insulin sensitivity and restores bone mass. J Clin Invest. 129(8):3214\u20133223. https:\/\/doi.org\/10.1172\/JCI125915","journal-title":"J Clin Invest."},{"issue":"6","key":"3725_CR24","doi-asserted-by":"publisher","first-page":"2613","DOI":"10.1002\/jcsm.13335","volume":"14","author":"L Slade","year":"2023","unstructured":"Slade L et al (2023) Bisphosphonates attenuate age-related muscle decline in Caenorhabditis elegans. J Cachexia Sarcopenia Muscle. 14(6):2613\u20132622. https:\/\/doi.org\/10.1002\/jcsm.13335","journal-title":"J Cachexia Sarcopenia Muscle."}],"container-title":["Internal and Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11739-024-03725-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11739-024-03725-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11739-024-03725-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,21]],"date-time":"2024-11-21T04:08:42Z","timestamp":1732162122000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11739-024-03725-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,2]]},"references-count":24,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["3725"],"URL":"https:\/\/doi.org\/10.1007\/s11739-024-03725-1","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-3903048\/v1","asserted-by":"object"}]},"ISSN":["1828-0447","1970-9366"],"issn-type":[{"value":"1828-0447","type":"print"},{"value":"1970-9366","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,2]]},"assertion":[{"value":"26 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors have no competing interests with any organization or entity with a financial interest in competition with the subject, matter or materials discussed in the manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was conducted in accordance with the Ethics Committee.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Informed consent was waived because of the retrospective nature of the study and the analysis used anonymous clinical data.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}